These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 17519792

  • 41. Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients.
    Tenderich G, Fuchs U, Zittermann A, Muckelbauer R, Berthold HK, Koerfer R.
    Clin Transplant; 2007; 21(4):536-43. PubMed ID: 17645716
    [Abstract] [Full Text] [Related]

  • 42. The effect of sirolimus in the development of chronic allograft nephropathy.
    Gürkan A, Kaçar S, Erdoğdu U, Varilsüha C, Kandemir G, Karaca C, Akman F.
    Transplant Proc; 2008; 40(1):114-6. PubMed ID: 18261561
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Five-year follow-up after late conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction.
    Krüger B, Fischereder M, Jauch KW, Graeb C, Hoffmann U, Böger CA, Banas B, Obed A, Schlitt HJ, Krämer BK.
    Transplant Proc; 2007 Mar; 39(2):518-21. PubMed ID: 17362772
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function.
    De Simone P, Carrai P, Precisi A, Petruccelli S, Baldoni L, Balzano E, Ducci J, Caneschi F, Coletti L, Campani D, Filipponi F.
    Transpl Int; 2009 Mar; 22(3):279-86. PubMed ID: 19054383
    [Abstract] [Full Text] [Related]

  • 49. Dyslipidemia during sirolimus therapy in patients after liver transplantation.
    Kniepeiss D, Iberer F, Schaffellner S, Jakoby E, Duller D, Tscheliessnigg Kh.
    Clin Transplant; 2004 Dec; 18(6):642-6. PubMed ID: 15516237
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Sirolimus for rescue of steroid and anti-thymocyte globulin-resistant recurrent acute rejection after liver transplantation: report of one case.
    Demirağ A, Kalayci M, Ekci B, Gülçelik T, Gökçe O.
    Transplant Proc; 2009 Dec; 41(1):435-6. PubMed ID: 19249574
    [Abstract] [Full Text] [Related]

  • 56. Accuracy and variability of equations to estimate glomerular filtration rates in renal transplant patients receiving sirolimus and/or calcineurin inhibitor immunosuppression.
    Burke JT, Brault Y, Kahan BD, Hricik DE, Grinyó JM, Chapman JR, Polinsky M, Neylan JF.
    Transpl Int; 2008 May; 21(5):434-40. PubMed ID: 18194393
    [Abstract] [Full Text] [Related]

  • 57. Is sirolimus responsible for proteinuria?
    Dervaux T, Caillard S, Meyer C, Ellero B, Woehl-Jaegle ML, Hannedouche T, Wolf P, Moulin B.
    Transplant Proc; 2005 May; 37(6):2828-9. PubMed ID: 16182822
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Sirolimus monotherapy as maintenance immunosuppression: single-center experience in 50 kidney transplant patients.
    Arellano EM, Campistol JM, Oppenheimer F, Rovira J, Diekmann F.
    Transplant Proc; 2007 Sep; 39(7):2131-4. PubMed ID: 17889115
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.